Raritan, NJ – December 21, 2009 — iContracts, a leading provider of solutions for managing corporate contracts, commitments, and compliance today announced that Edenbridge Pharmaceuticals™, LLC, a Pharmaceutical Company focused on identifying, developing and marketing specialty generic pharmaceutical products for a better world, has selected solutions from iContracts™ to manage core processes including the processing, reconciliation, and payment of distributor chargebacks and associated transactions on iContracts’ Better Contracting Solutions (BCS) platform.
iContracts robust solutions will enable Edenbridge to manage these complex processes in a unified environment and to expand to additional iContracts’ modules as their company grows – without the cost and long timelines associated with alternatives. Edenbridge will access iContracts solutions as a software service over the web, thus requiring no investment in facilities, hardware, software, or related costs.
Ryan Collins, Chief Executive Officer of Edenbridge Pharmaceuticals™, commented “iContracts has certainly changed the playing field for pharmaceutical manufacturers looking for solutions to manage critical chargeback, rebate, Medicaid, and Government Pricing processes. They have managed to turn a process that for many companies is an expensive administrative and implementation quagmire into a highly automated, short time-to-benefit platform and solution that is truly unique. We look forward to working with iContracts on this important project and to a long and fruitful relationship for many years to come.”
“We are gratified to be working with a company like Edenbridge Pharmaceuticals™ who believe they can contribute to making the world a better place by providing unique alternatives where none existed before.”, commented A. Leigh Powell, Chief Executive Officer of iContracts.” “We believe that by de-mystifying the process of managing contracts and compliance and delivering solutions that allow companies like Edenbridge to devote more time and resources to developing high-quality affordable drugs and invest less on software solutions and consultants, in our own small way, we too are making a valuable contribution. iContracts looks forward to partnering on this and many other initiatives in the future”.
iContracts solutions are available as an “on demand” service or as a behind-the-firewall offering and are built on iContracts’s revolutionary BCS platform featuring an advanced data architecture, rich functionality and Simplified Common User Interface (SCUI) enabling users to execute any process after learning just two basic screen formats. This groundbreaking design drastically reduces implementation; training and future upgrade timeframes and costs.
About iContracts – iContracts’ goal is simple – to deliver better solutions for managing contracts that are faster, easier and less expensive to implement. This mantra is reflected in everything we do. Our software is generations ahead of other solutions, powered by a Simplified Common User Interface (SCUI) that makes every user an “expert” by learning just two simple, reusable views and backed by the most highly evolved data architecture in the industry – built by technologists with more experience in building contract management solutions for the Life Sciences industry than anyone on the planet! This deep understanding and straightforward approach shows in everything we do. iContracts comprehensive suite of solutions manages all aspects of a Life Science company’s chargeback, rebate and Medicaid processes as well as other incentive agreements and Government Pricing compliance at all levels. Our solutions are enterprise-class and can be quickly and easily integrated with any off-the-shelf or custom system to meet exacting business requirements without the army of consultants and endless fees associated with other products and providers. For more information, please visit www.icontracts.com.
About Edenbridge – Edenbridge Pharmaceuticals™ is focused on identifying, developing and marketing specialty generic pharmaceutical products for a better world. Our goal is to create a broad portfolio of limited source products that will provide high-quality, affordable and accessible healthcare alternatives for physicians and patients everywhere. Edenbridge’s approach to the generic pharmaceutical market centers upon the development of safe and established products that have until now failed to attract the attention of high-quality drug development companies. We believe that our product portfolio will provide true alternatives to consumers in contrast to the products offered by so many of our competitors. Edenbridge is creating opportunities where others see only difficulty. For more information, please visit www.edenbridgepharma.com.
iContracts Media Contact:
Anne Ambrosio
iContracts, Inc.
Tel: 908-393-9550
aambrosio@icontracts.com